| __timestamp | Amneal Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 2242216 |
| Thursday, January 1, 2015 | 136870000 | 4536244 |
| Friday, January 1, 2016 | 204747000 | 5184803 |
| Sunday, January 1, 2017 | 191938000 | 3068742 |
| Monday, January 1, 2018 | 210451000 | 7178000 |
| Tuesday, January 1, 2019 | 202287000 | 16267000 |
| Wednesday, January 1, 2020 | 190585000 | 23191000 |
| Friday, January 1, 2021 | 209563000 | 21453000 |
| Saturday, January 1, 2022 | 200046000 | 15265000 |
| Sunday, January 1, 2023 | 167778000 | 25189000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Amneal Pharmaceuticals and Soleno Therapeutics have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amneal Pharmaceuticals consistently allocated substantial resources to R&D, with expenditures peaking in 2018 at approximately 210 million dollars. This represents a 97% increase from their 2014 spending. In contrast, Soleno Therapeutics, while starting with a modest R&D budget, showed a remarkable growth trajectory, increasing their spending by over 1,000% from 2014 to 2023, reaching nearly 25 million dollars. This strategic focus highlights Soleno's aggressive push towards innovation, despite their smaller scale. As the pharmaceutical industry continues to evolve, these investment patterns may well dictate future market leadership and breakthroughs.
R&D Insights: How AbbVie Inc. and Amneal Pharmaceuticals, Inc. Allocate Funds
AstraZeneca PLC vs Amneal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Amneal Pharmaceuticals, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Amneal Pharmaceuticals, Inc. and MannKind Corporation
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.